Envestnet Portfolio Solutions Inc. Has $2.87 Million Stock Position in Aflac Incorporated (NYSE:AFL)

Envestnet Portfolio Solutions Inc. grew its position in Aflac Incorporated (NYSE:AFL) by 3.3% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 27,717 shares of the financial services provider’s stock after purchasing an additional 876 shares during the period. Envestnet Portfolio Solutions Inc.’s holdings in Aflac were worth $2,867,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the company. Franklin Resources Inc. increased its holdings in Aflac by 75.2% in the third quarter. Franklin Resources Inc. now owns 776,131 shares of the financial services provider’s stock worth $88,533,000 after buying an additional 333,083 shares during the last quarter. Transamerica Financial Advisors Inc. bought a new position in shares of Aflac during the 3rd quarter valued at $979,000. Roxbury Financial LLC acquired a new stake in shares of Aflac in the 4th quarter valued at $948,000. FMR LLC increased its position in Aflac by 4.0% during the third quarter. FMR LLC now owns 1,202,104 shares of the financial services provider’s stock worth $134,395,000 after buying an additional 45,745 shares during the last quarter. Finally, Willis Investment Counsel raised its holdings in Aflac by 1.2% during the fourth quarter. Willis Investment Counsel now owns 273,466 shares of the financial services provider’s stock valued at $28,287,000 after buying an additional 3,357 shares in the last quarter. 67.44% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

AFL has been the subject of several recent analyst reports. StockNews.com upgraded Aflac from a “sell” rating to a “hold” rating in a research note on Friday, February 14th. Evercore ISI decreased their target price on Aflac from $104.00 to $102.00 and set an “underperform” rating for the company in a research report on Wednesday, December 4th. Piper Sandler dropped their price target on shares of Aflac from $122.00 to $118.00 and set an “overweight” rating on the stock in a research report on Friday, February 7th. Morgan Stanley upped their price objective on shares of Aflac from $98.00 to $105.00 and gave the stock an “equal weight” rating in a report on Friday, February 28th. Finally, Wells Fargo & Company cut their target price on shares of Aflac from $104.00 to $102.00 and set an “equal weight” rating for the company in a research report on Wednesday, February 19th. Two equities research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $103.36.

Aflac Price Performance

Shares of NYSE:AFL opened at $108.49 on Thursday. The firm has a market capitalization of $59.30 billion, a PE ratio of 11.30, a PEG ratio of 3.24 and a beta of 0.93. The company has a current ratio of 0.10, a quick ratio of 0.08 and a debt-to-equity ratio of 0.29. Aflac Incorporated has a 1-year low of $79.31 and a 1-year high of $115.50. The business’s 50 day moving average is $105.70 and its 200-day moving average is $107.65.

Aflac (NYSE:AFL) last announced its quarterly earnings results on Wednesday, February 5th. The financial services provider reported $1.56 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.63 by ($0.07). Aflac had a net margin of 28.76% and a return on equity of 16.20%. Sell-side analysts predict that Aflac Incorporated will post 6.88 earnings per share for the current year.

Insider Buying and Selling

In other Aflac news, EVP Audrey B. Tillman sold 24,744 shares of the company’s stock in a transaction on Friday, December 27th. The stock was sold at an average price of $103.40, for a total value of $2,558,529.60. Following the sale, the executive vice president now directly owns 222,618 shares in the company, valued at $23,018,701.20. This represents a 10.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director Charles D. Lake II sold 29,802 shares of Aflac stock in a transaction on Monday, March 10th. The shares were sold at an average price of $107.29, for a total value of $3,197,456.58. Following the transaction, the director now directly owns 49,962 shares of the company’s stock, valued at approximately $5,360,422.98. The trade was a 37.36 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 55,546 shares of company stock valued at $5,863,616 over the last quarter. Corporate insiders own 0.80% of the company’s stock.

Aflac Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.